{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:03:06Z","timestamp":1791910986230,"version":"4.3.4"},"reference-count":72,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T00:00:00Z","timestamp":1517184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Janssen Prevention Centre"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0190615","type":"journal-article","created":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T18:28:19Z","timestamp":1517250499000},"page":"e0190615","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["The development of a stochastic mathematical model of Alzheimer\u2019s disease to help improve the design of clinical trials of potential treatments"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6166-5899","authenticated-orcid":true,"given":"Christoforos","family":"Hadjichrysanthou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison K.","family":"Ower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"de Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy M.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Alzheimer's Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,1,29]]},"reference":[{"issue":"4a","key":"ref1","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/S0002-9343(98)00022-9","article-title":"The initial recognition and diagnosis of dementia","volume":"104","author":"DS Knopman","year":"1998","journal-title":"The American journal of medicine"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jalz.2010.11.007","article-title":"National estimates of the prevalence of Alzheimer&apos;s disease in the United States*","volume":"7","author":"R Brookmeyer","year":"2011","journal-title":"Alzheimer's & dementia: the journal of the Alzheimer's Association"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jalz.2007.04.381","article-title":"Forecasting the global burden of Alzheimer&apos;s disease","volume":"3","author":"R Brookmeyer","year":"2007","journal-title":"Alzheimers Dement"},{"key":"ref4","article-title":"World Alzheimer Report 2016\u2014Improving healthcare for people living with dementia: Coverage, quality and costs now and in the future","author":"M Prince","year":"2016"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000090733","article-title":"An estimate of the worldwide prevalence and direct costs of dementia in 2003","volume":"21","author":"A Wimo","year":"2006","journal-title":"Dementia and geriatric cognitive disorders"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/geront\/43.2.158","article-title":"Cost of Illness of Alzheimer&apos;s Disease: How Useful Are Current Estimates?","volume":"43","author":"BS Bloom","year":"2003","journal-title":"The Gerontologist"},{"issue":"5580","key":"ref7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer&apos;s disease: progress and problems on the road to therapeutics","volume":"297","author":"J Hardy","year":"2002","journal-title":"Science (New York, NY)"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3233\/JAD-2006-9S317","article-title":"Alzheimer&apos;s disease: the amyloid cascade hypothesis: an update and reappraisal","volume":"9","author":"J Hardy","year":"2006","journal-title":"Journal of Alzheimer's disease: JAD"},{"issue":"522","key":"ref9","article-title":"Alzheimer&apos;s disease: the amyloid hypothesis and the Inverse Warburg effect","volume":"5","author":"LA Demetrius","year":"2015","journal-title":"Frontiers in Physiology"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","article-title":"The Cellular Phase of Alzheimer&apos;s Disease","volume":"164","author":"B De Strooper","year":"2016","journal-title":"Cell"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1474-4422(16)00062-4","article-title":"Defeating Alzheimer&apos;s disease and other dementias: a priority for European science and society","volume":"15","author":"B Winblad","year":"2016","journal-title":"The Lancet Neurology"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/scientificamerican0417-32","article-title":"A Rare Success against Alzheimer&apos;s","volume":"316","author":"M Kivipelto","year":"2017","journal-title":"Scientific American"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt269","article-title":"Alzheimer\u2019s disease drug-development pipeline: few candidates, frequent failures","volume":"6","author":"JL Cummings","year":"2014","journal-title":"Alzheimer's Research & Therapy"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2147\/CEOR.S22265","article-title":"Impact of early intervention and disease modification in patients with predementia Alzheimer&apos;s disease: a Markov model simulation","volume":"3","author":"D Budd","year":"2011","journal-title":"ClinicoEconomics and outcomes research: CEOR"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jalz.2015.12.003","article-title":"Why has therapy development for dementia failed in the last two decades?","volume":"12","author":"S Gauthier","year":"2016","journal-title":"Alzheimer's & Dementia"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s00285-013-0732-0","article-title":"Alzheimer\u2019s disease: analysis of a mathematical model incorporating the role of prions","volume":"69","author":"M Helal","year":"2014","journal-title":"J Math Biol"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1006\/bulm.2002.0304","article-title":"A mathematical model of the impact of novel treatments on the A\u03b2 burden in the Alzheimer\u2019s brain, CSF and plasma","volume":"64","author":"D Craft","year":"2002","journal-title":"Bull Math Biol"},{"key":"ref18","article-title":"Alzheimer\u2019s disease: A mathematical model for onset and progression","author":"M Bertsch","year":"2015","journal-title":"arXiv"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"e15176","DOI":"10.1371\/journal.pone.0015176","article-title":"Mathematical Modeling for the Pathogenesis of Alzheimer&apos;s Disease","volume":"5","author":"IK Puri","year":"2010","journal-title":"PLoS ONE"},{"issue":"9","key":"ref20","doi-asserted-by":"crossref","first-page":"e73631","DOI":"10.1371\/journal.pone.0073631","article-title":"Investigating Interventions in Alzheimer&apos;s Disease with Computer Simulation Models","volume":"8","author":"CJ Proctor","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11920-001-0067-1","article-title":"Modeling the time-course of Alzheimer dementia","volume":"3","author":"JW Ashford","year":"2001","journal-title":"Current psychiatry reports"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/0962280211406470","article-title":"A multi-state model for the analysis of changes in cognitive scores over a fixed time interval","volume":"23","author":"AB Mitnitski","year":"2011","journal-title":"Statistical methods in medical research"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jalz.2010.03.018","article-title":"Disease progression model for cognitive deterioration from Alzheimer&apos;s Disease Neuroimaging Initiative database","volume":"7","author":"K Ito","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/0091270011405497","article-title":"An improved model for disease progression in patients from the Alzheimer&apos;s disease neuroimaging initiative","volume":"52","author":"MN Samtani","year":"2012","journal-title":"Journal of clinical pharmacology"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10928-012-9263-3","article-title":"Combining patient-level and summary-level data for Alzheimer&apos;s disease modeling and simulation: a beta regression meta-analysis","volume":"39","author":"JA Rogers","year":"2012","journal-title":"Journal of pharmacokinetics and pharmacodynamics"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13195-014-0079-9","article-title":"Fitting the epidemiology and neuropathology of the early stages of Alzheimer&apos;s disease to prevent dementia","volume":"7","author":"J Mar","year":"2015","journal-title":"Alzheimers Res Ther"},{"issue":"01","key":"ref27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2143\/AST.30.1.504627","article-title":"A Mathematical Model of Alzheimer&apos;s Disease and the Apoe Gene","volume":"30","author":"A Macdonald","year":"2000","journal-title":"ASTIN Bulletin"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jalz.2010.03.006","article-title":"Clinical Core of the Alzheimer&apos;s Disease Neuroimaging Initiative: progress and plans","volume":"6","author":"PS Aisen","year":"2010","journal-title":"Alzheimers Dement"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","article-title":"The clinical use of structural MRI in Alzheimer disease","volume":"6","author":"GB Frisoni","year":"2010","journal-title":"Nature reviews Neurology"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade","volume":"9","author":"CR Jack","year":"2010","journal-title":"Lancet neurology"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","article-title":"Biomarker modeling of Alzheimer&apos;s disease","volume":"80","author":"CR Jack Jr.","year":"2013","journal-title":"Neuron"},{"issue":"10","key":"ref32","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/archneurol.2011.123","article-title":"Longitudinal change of biomarkers in cognitive decline","volume":"68","author":"RY Lo","year":"2011","journal-title":"Archives of neurology"},{"issue":"9","key":"ref33","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.biopsych.2011.04.023","article-title":"Regional expansion of hypometabolism in Alzheimer&apos;s disease follows amyloid deposition with temporal delay","volume":"71","author":"S Forster","year":"2012","journal-title":"Biological psychiatry"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/ana.23650","article-title":"Amyloid deposition, hypometabolism, and longitudinal cognitive decline","volume":"72","author":"SM Landau","year":"2012","journal-title":"Annals of neurology"},{"issue":"9","key":"ref35","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and Biomarker Changes in Dominantly Inherited Alzheimer&apos;s Disease","volume":"367","author":"RJ Bateman","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archgenpsychiatry.2011.155","article-title":"Cerebrospinal fluid levels of beta-amyloid 1\u201342, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia","volume":"69","author":"P Buchhave","year":"2012","journal-title":"Archives of general psychiatry"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer&apos;s disease: a prospective cohort study","volume":"12","author":"VL Villemagne","year":"2013","journal-title":"The Lancet Neurology"},{"issue":"Pt 9","key":"ref38","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1093\/brain\/awu176","article-title":"A data-driven model of biomarker changes in sporadic Alzheimer&apos;s disease","volume":"137","author":"AL Young","year":"2014","journal-title":"Brain: a journal of neurology"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.media.2015.07.004","article-title":"A simulation system for biomarker evolution in neurodegenerative disease","volume":"26","author":"AL Young","year":"2015","journal-title":"Medical image analysis"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/j.neuroimage.2012.01.062","article-title":"An event-based model for disease progression and its application in familial Alzheimer&apos;s disease and Huntington&apos;s disease","volume":"60","author":"HM Fonteijn","year":"2012","journal-title":"NeuroImage"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jval.2010.12.008","article-title":"Model-based economic evaluation in Alzheimer&apos;s disease: a review of the methods available to model Alzheimer&apos;s disease progression","volume":"14","author":"C Green","year":"2011","journal-title":"Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research"},{"issue":"6","key":"ref42","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1212\/WNL.57.6.957","article-title":"Measuring Alzheimer&apos;s disease progression with transition probabilities: estimates from CERAD","volume":"57","author":"PJ Neumann","year":"2001","journal-title":"Neurology"},{"issue":"3","key":"ref43","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/gps.1076","article-title":"Measuring Alzheimer&apos;s disease progression with transition probabilities in the Taiwanese population","volume":"19","author":"JL Fuh","year":"2004","journal-title":"International journal of geriatric psychiatry"},{"issue":"6","key":"ref44","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1212\/01.wnl.0000203264.71880.45","article-title":"Risk factors for transitions from normal to mild cognitive impairment and dementia","volume":"66","author":"RJ Kryscio","year":"2006","journal-title":"Neurology"},{"issue":"11","key":"ref45","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/aje\/kwm085","article-title":"Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study","volume":"165","author":"SL Tyas","year":"2007","journal-title":"American journal of epidemiology"},{"issue":"9","key":"ref46","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2174\/156720512803569046","article-title":"Measuring Alzheimer disease progression with transition probabilities: estimates from NACC-UDS","volume":"9","author":"DE Spackman","year":"2012","journal-title":"Current Alzheimer research"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1155\/2012\/291920","article-title":"Mild Cognitive Impairment: Statistical Models of Transition Using Longitudinal Clinical Data","volume":"2012","author":"EL Abner","year":"2012","journal-title":"International Journal of Alzheimer's Disease"},{"issue":"7","key":"ref48","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/(SICI)1099-1166(199807)13:7<445::AID-GPS794>3.0.CO;2-E","article-title":"Pharmacotherapy for people with Alzheimer&apos;s disease: a Markov-cycle evaluation of five years&apos; therapy using donepezil","volume":"13","author":"A Stewart","year":"1998","journal-title":"International journal of geriatric psychiatry"},{"issue":"9","key":"ref49","first-page":"607","article-title":"Cost effectiveness of memantine in Alzheimer&apos;s disease: an analysis based on a probabilistic Markov model from a UK perspective","volume":"21","author":"RW Jones","year":"2004","journal-title":"Drugs & aging"},{"issue":"10","key":"ref50","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1080\/02664763.2010.547567","article-title":"A comparison of non-homogeneous Markov regression models with application to Alzheimer&apos;s disease progression","volume":"38","author":"RA Hubbard","year":"2011","journal-title":"Journal of applied statistics"},{"issue":"5","key":"ref51","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0022-3956(02)00020-1","article-title":"Modeling the prevalence and incidence of Alzheimer\u2019s disease and mild cognitive impairment","volume":"36","author":"JA Yesavage","year":"2002","journal-title":"Journal of Psychiatric Research"},{"key":"ref52","unstructured":"Alzheimer&apos;s Disease Neuroimaging Initiative. [<ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/adni.loni.usc.edu\/wp-content\/uploads\/2008\/07\/adni2-procedures-manual.pdf\" xlink:type=\"simple\">http:\/\/adni.loni.usc.edu\/wp-content\/uploads\/2008\/07\/adni2-procedures-manual.pdf<\/ext-link>]."},{"issue":"1","key":"ref53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1212\/WNL.56.1.37","article-title":"Classification criteria for mild cognitive impairment: a population-based validation study","volume":"56","author":"K Ritchie","year":"2001","journal-title":"Neurology"},{"issue":"7","key":"ref54","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1001\/archneur.62.7.1164","article-title":"Mild cognitive impairment is not a clinical entity and should not be treated","volume":"62","author":"S Gauthier","year":"2005","journal-title":"Archives of neurology"},{"issue":"1","key":"ref55","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1212\/01.WNL.0000132523.27540.81","article-title":"Mild cognitive impairment, amnestic type: an epidemiologic study","volume":"63","author":"M Ganguli","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"ref56","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000151635","article-title":"Clinical Features of Mild Cognitive Impairment Differ in the Research and Tertiary Clinic Settings","volume":"26","author":"GA Jicha","year":"2008","journal-title":"Dementia and geriatric cognitive disorders"},{"issue":"7618","key":"ref57","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease","volume":"537","author":"J Sevigny","year":"2016","journal-title":"Nature"},{"issue":"2","key":"ref58","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1474-4422(16)30395-7","article-title":"Solanezumab: too late in mild Alzheimer&apos;s disease?","volume":"16","year":"2017","journal-title":"The Lancet Neurology"},{"issue":"4","key":"ref59","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/NEN.0b013e31824b211b","article-title":"Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer&apos;s Disease Centers, 2005\u20132010","volume":"71","author":"TG Beach","year":"2012","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"ref60","doi-asserted-by":"crossref","DOI":"10.1201\/9780429246593","article-title":"An Introduction to the Bootstrap","author":"B Efron","year":"1994"},{"issue":"1","key":"ref61","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/hec.654","article-title":"Estimation of the transition matrix of a discrete-time Markov chain","volume":"11","author":"BA Craig","year":"2002","journal-title":"Health economics"},{"issue":"1","key":"ref62","doi-asserted-by":"crossref","DOI":"10.4172\/2155-6180.1000e122","article-title":"Are Markov and semi-Markov models flexible enough for cognitive panel data?","volume":"4","author":"RJ Kryscio","year":"2013","journal-title":"Journal of biometrics & biostatistics"},{"issue":"5","key":"ref63","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1076\/jcen.25.5.589.14571","article-title":"The concept of cognitive reserve: a catalyst for research","volume":"25","author":"Y Stern","year":"2003","journal-title":"Journal of clinical and experimental neuropsychology"},{"issue":"Suppl 2","key":"ref64","first-page":"S50","article-title":"Brain reserve and the clinical expression of Alzheimer&apos;s disease","volume":"52","author":"JA Mortimer","year":"1997","journal-title":"Geriatrics"},{"issue":"6","key":"ref65","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1017\/S0033291797005461","article-title":"The effects of intelligence and education on the development of dementia. A test of the brain reserve hypothesis","volume":"27","author":"B Schmand","year":"1997","journal-title":"Psychological medicine"},{"issue":"5","key":"ref66","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/j.jalz.2013.05.1769","article-title":"The Alzheimer&apos;s Disease Neuroimaging Initiative: a review of papers published since its inception","volume":"9","author":"MW Weiner","year":"2013","journal-title":"Alzheimers Dement"},{"issue":"5","key":"ref67","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/archneurol.2011.3029","article-title":"Comparison of imaging biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of Aging","volume":"69","author":"JL Whitwell","year":"2012","journal-title":"Archives of neurology"},{"issue":"2","key":"ref68","doi-asserted-by":"crossref","first-page":"111","DOI":"10.31887\/DCNS.2009.11.2\/cqiu","article-title":"Epidemiology of Alzheimer&apos;s disease: occurrence, determinants, and strategies toward intervention","volume":"11","author":"C Qiu","year":"2009","journal-title":"Dialogues in clinical neuroscience"},{"key":"ref69","article-title":"Temporal association patterns and dynamics of amyloid-\u03b2 and tau in Alzheimer\u2019s disease","author":"AK Ower","year":"2017","journal-title":"European Journal of Epidemiology"},{"issue":"3","key":"ref70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt183","article-title":"Modeling the course of Alzheimer&apos;s disease to improve clinical trials: symposium report","volume":"5","author":"R Spiegel","year":"2013","journal-title":"Alzheimer's Research & Therapy"},{"issue":"4","key":"ref71","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12603-010-0066-1","article-title":"The potential and limits for clinical trials for early Alzheimer&apos;s disease and some recommendations","volume":"14","author":"LS Schneider","year":"2010","journal-title":"The journal of nutrition, health & aging"},{"issue":"10","key":"ref72","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s10654-017-0320-5","article-title":"Trends in the incidence of dementia: design and methods in the Alzheimer Cohorts Consortium","volume":"32","author":"LB Chibnik","year":"2017","journal-title":"European Journal of Epidemiology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0190615","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T11:47:37Z","timestamp":1660391257000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0190615"}},"subtitle":[],"editor":[{"given":"Stephen D.","family":"Ginsberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,1,29]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0190615","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,29]]}}}